| Post marketing reports of infrequent (< 1/1000) reports of psychotic
depression which may or may not have causal relationship to the use
of glatiramer acetate.
Suicide attempt was also listed as infrequent.
It is unknown whether these events are related to exposure to glatiramer
acetate (Copaxone ®).
|
